Cargando…

Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer

Detalles Bibliográficos
Autores principales:	Hatakeyama, Shingo, Koie, Takuya, Narita, Takuma, Hosogoe, Shogo, Yamamoto, Hayato, Tobisawa, Yuki, Yoneyama, Tohru, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Ohyama, Chikara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792434/ https://www.ncbi.nlm.nih.gov/pubmed/26978781 http://dx.doi.org/10.1371/journal.pone.0151742

Ejemplares similares

Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction
por: Narita, Takuma, et al.
Publicado: (2017)

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery
por: Sato, Tendo, et al.
Publicado: (2016)

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer
por: Koie, Takuya, et al.
Publicado: (2014)

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer
por: Kusaka, Ayumu, et al.
Publicado: (2017)

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer
por: Hamano, Itsuto, et al.
Publicado: (2017)

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis
por: Koie, Takuya, et al.
Publicado: (2014)

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan
por: Koie, Takuya, et al.
Publicado: (2015)

Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer
por: Fujita, Naoki, et al.
Publicado: (2022)

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma
por: Hosogoe, Shogo, et al.
Publicado: (2017)

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma
por: Momota, Masaki, et al.
Publicado: (2018)

Testicular Metastasis of Prostate Cancer: A Case Report
por: Kusaka, Ayumu, et al.
Publicado: (2014)

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents
por: Hamano, Itsuto, et al.
Publicado: (2016)

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer
por: Fujita, Naoki, et al.
Publicado: (2023)

Narrative review of urinary glycan biomarkers in prostate cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2021)

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy
por: Fukushi, Ken, et al.
Publicado: (2017)

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers
por: Soma, Osamu, et al.
Publicado: (2018)

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study
por: Anan, Go, et al.
Publicado: (2017)

Robotic cross‐folded U‐configuration intracorporeal ileal neobladder for muscle‐invasive bladder cancer: Initial experience and functional outcomes
por: Koie, Takuya, et al.
Publicado: (2018)

Salvage Brachytherapy for Castration-Resistant and External Beam Radiotherapy-Resistant Local Recurrence 17 Years after Radical Prostatectomy
por: Hosogoe, Shogo, et al.
Publicado: (2015)

I‐branching N‐acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling
por: Mikami, Jotaro, et al.
Publicado: (2016)

Clinical relevance of aortic calcification in urolithiasis patients
por: Tanaka, Toshikazu, et al.
Publicado: (2017)

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries
por: Konishi, Sakae, et al.
Publicado: (2021)

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Iwamura, Hiromichi, et al.
Publicado: (2022)

Recent progress and perspectives on prostate cancer biomarkers
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study
por: Fujita, Naoki, et al.
Publicado: (2023)

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study
por: Hamaya, Tomoko, et al.
Publicado: (2021)

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis
por: Tanaka, Yoshimi, et al.
Publicado: (2017)

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
por: Matsumoto, Teppei, et al.
Publicado: (2019)

A Case of Primary Renal Carcinoid Tumor
por: Tanaka, Toshikazu, et al.
Publicado: (2015)

Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report
por: Koie, Takuya, et al.
Publicado: (2013)

Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer
por: Kojima, Yuta, et al.
Publicado: (2015)

Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer
por: Hagiwara, Kazuhisa, et al.
Publicado: (2017)

Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids
por: Ishii, Noritaka, et al.
Publicado: (2022)

Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis
por: Hatakeyama, Shingo, et al.
Publicado: (2013)

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
por: Fujita, Naoki, et al.
Publicado: (2023)

Renal cell carcinoma in a lumbar ectopic kidney
por: Hamano, Itsuto, et al.
Publicado: (2019)

Tubulocystic renal cell carcinoma in the left kidney: a case report
por: Ishibashi, Yusuke, et al.
Publicado: (2014)

Robot‐assisted radical cystectomy in a patient with muscle‐invasive bladder cancer following radiotherapy for prostate cancer
por: Kubota, Yuka, et al.
Publicado: (2019)

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma
por: Horiguchi, Hirotaka, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aplfk5nr042b8aij44c0h06jqe